Definitive Contract 75N93024C00028
Award Date
9/1/24
Potential Completion Date
8/31/25
Potential Value
$300K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Luna Labs USA LLC
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Charlottesville, VA, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Small Business Innovation Research (SBIR) Phase II contract to Luna Innovations Incorporated, a manufacturer of goods, for the development of "Innovative Oral Formulations for Anti-TB Drugs". The firm-fixed-price contract, with a potential value of $1,499,796.00, was awarded on August 28, 2018, and is set to be completed by November 30, 2020. As a...
This contract was awarded by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) to Luna Labs USA LLC, a division of Luna Innovations Incorporated. The $599,993.00 award falls under the Small Business Innovation Research (SBIR) program and is for the development of "Reagents for Immunologic Analysis of Non-mammalian and Underrepresented Mammalian Models." Luna Labs USA LLC is a small...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institutes of Health (NIH), part of the Department of Health and Human Services (HHS), to Luna Innovations Incorporated. The objective of this $299,956 Firm Fixed Price contract is to develop a novel layer-by-layer (LBL) RNA vaccine that can provide long-lasting protection against HIV. Luna Innovations is a small business that specializes in fiber optic sensing and measurement systems, and has previously...
This is a $300,000.00 Small Business Innovation Research (SBIR) Program Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Luna Labs USA LLC, a small business manufacturer based in Charlottesville, Virginia. The contract is for the development of a rapid nucleic acid test for HIV-1, with a period of performance through April 2025. The contract includes two subcontractors - Gener8, LLC, a medical device manufacturer providing engineering services...
This is a firm fixed-price definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Luna Labs USA LLC, a division of Luna Innovations Incorporated. The contract, valued at $1,499,998.00, is for the development of innovative pediatric oral formulations for second-line tuberculosis drugs. This contract is set aside for small businesses. Luna Labs USA LLC, a leading provider of advanced...
This is a $299,999.00 Firm Fixed Price Definitive Contract awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Luna Innovations Incorporated, a small business manufacturer, for the CNT-VECTORED DELIVERY OF MRNA FOR HIV-VACCINES research project under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for the development and delivery of products and services related to this...
This is a $1,299,999.31 Firm Fixed Price contract awarded by the Defense Health Agency (DHA) to Luna Labs USA LLC, a small business manufacturer based in Charlottesville, Virginia. The contract is for STTR Phase II research and development of "shelf-stable antibiotic hybrid exosomes for the topical treatment of wound infections". This is a medical research and development contract with a period of performance through June 4, 2027. The contract was set aside for small businesses. Luna...
This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Luna Labs USA LLC, a subsidiary of Luna Innovations Incorporated, for the development of a platform for the delivery of mRNA-based HIV vaccines. The $1,999,997.00 Firm-Fixed-Price contract involves collaborating with New York University (NYU) to evaluate the immunogenicity of novel HIV...
This is a $224,953.00 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Luna Innovations Incorporated, a small business manufacturer, under the SBIR program. The contract is for the development and delivery of a "Magnetic Microparticle Kit for Cell Removal from Blood" and has a period of performance ending on August 17, 2016. This contract is for Phase I research and development under the SBIR program, which supports small...
This is a $149,999.78 Firm Fixed Price contract awarded by the Department of the Army Medical Command to Luna Innovations Incorporated, a for-profit manufacturer, under the Small Business Technology Transfer (STTR) Phase I program. The contract is for the development of a "Malaria Shield Delivery System: Long-Term Malarial Chemoprophylactic Drug Releasing Implant", which is a research and development topic under the Army's STTR program. The contract has a completion date of September...